MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12876-025-04561-z

Медицинская библиотека · BMC gastroenterology · 2025

Clinicopathological features of steroid-refractory immune-mediated hepatotoxicity induced by immune checkpoint inhibitors.

Hioki Tomonobu, Imoto Koji, Goya Takeshi, Azuma Yuki, Horiuchi Atsushi, Aoyagi Tomomi, Takahashi Motoi, Oda Yoshinao, Kato Masaki, Kohjima Motoyuki, Tanaka Masatake, Ogawa Yoshihiro

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Mycophenolate mofetil (MMF) is a second-line agent for steroid-refractory immune checkpoint inhibitor-induced immune-mediated hepatotoxicity (IMH). However, the clinicopathologic characteristics and the efficacy and safety of MMF for steroid-refractory IMH are not fully understood.

METHODS

This retrospective study enrolled 33 patients with pathologically diagnosed IMH by liver biopsy at Kyushu University Hospital between 2017 and 2023.

RESULTS

Prednisolone (PSL) was administered as steroid monotherapy in 13 patients who were steroid-responsive or in combination with MMF in 10 patients who were steroid-refractory. Of the 10 steroid-refractory IMH cases, 9 eventually improved, but 1 was refractory to PSL + MMF. There were no adverse events related to MMF. Pathological evaluation revealed significantly more frequent cholangitis in the steroid-refractory group than in the steroid-responsive group [70.0% vs. 27.8%, p = 0.042]. The steroid-refractory IMH cases were further categorized into the MMF responder and MMF non-responder groups, according to the decreased level of alanine aminotransferase (ALT) 1 week before and after MMF initiation. Compared with the MMF responder group, the MMF non-responder group had significantly higher number of patients with cholestatic and mixed patterns and significantly longer interval from PSL initiation to MMF initiation [29 days (range: 21-60 days) vs. 20 days (range: 10-20 days), p = 0.0048].

CONCLUSIONS

This study is the first to demonstrate that cholangitis is more prominent in steroid-refractory IMH. MMF is a safe and effective second-line treatment, and its early induction should be considered in patients with histological evidence of cholangitis.

Для цитирования: Hioki Tomonobu, Imoto Koji, Goya Takeshi, Azuma Yuki, Horiuchi Atsushi, Aoyagi Tomomi, Takahashi Motoi, Oda Yoshinao, Kato Masaki, Kohjima Motoyuki, Tanaka Masatake, Ogawa Yoshihiro. Clinicopathological features of steroid-refractory immune-mediated hepatotoxicity induced by immune checkpoint inhibitors.. BMC gastroenterology. 2025. DOI: 10.1186/s12876-025-04561-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.